| __timestamp | Alpine Immune Sciences, Inc. | Amphastar Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 28427000 |
| Thursday, January 1, 2015 | 16054000 | 37065000 |
| Friday, January 1, 2016 | 23316000 | 41199000 |
| Sunday, January 1, 2017 | 10626000 | 43415000 |
| Monday, January 1, 2018 | 28970000 | 57564000 |
| Tuesday, January 1, 2019 | 35847000 | 68853000 |
| Wednesday, January 1, 2020 | 27185000 | 67229000 |
| Friday, January 1, 2021 | 58742000 | 60932000 |
| Saturday, January 1, 2022 | 70243000 | 74771000 |
| Sunday, January 1, 2023 | 80904000 | 73741000 |
Unleashing insights
In the competitive world of biotechnology and pharmaceuticals, innovation is the key to success. Alpine Immune Sciences, Inc. and Amphastar Pharmaceuticals, Inc. are two companies that have consistently invested in research and development (R&D) over the past decade. From 2014 to 2023, Alpine Immune Sciences increased its R&D spending by over 560%, starting from approximately $12 million in 2014 to over $80 million in 2023. Meanwhile, Amphastar Pharmaceuticals also showed a robust growth of 160% in its R&D expenses, from around $28 million in 2014 to nearly $74 million in 2023.
While both companies have shown a commitment to innovation, Alpine Immune Sciences has demonstrated a more aggressive growth trajectory in its R&D investments. This trend highlights the company's strategic focus on pioneering new treatments and therapies, potentially positioning it as a leader in the biotech industry.
R&D Insights: How Incyte Corporation and Alpine Immune Sciences, Inc. Allocate Funds
Comparing Innovation Spending: Incyte Corporation and Amphastar Pharmaceuticals, Inc.
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Halozyme Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Opthea Limited vs Amphastar Pharmaceuticals, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.
Comparing Innovation Spending: Wave Life Sciences Ltd. and Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. or MannKind Corporation: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Amphastar Pharmaceuticals, Inc. and Celldex Therapeutics, Inc.
R&D Insights: How Amphastar Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. Allocate Funds